Trial
NCT02584829
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
EMD Serono; National Cancer Institute (NCI)
Condition
Merkel Cell Polyomavirus Infection
Intervention
Avelumab
Why stopped
Terminated due to loss in funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-22